Einfach Bitcoin kaufen: Mit dem Code "FINANZEN" sparen Sie 21% der Gebühren für 6 Monate bei Coinfinity. Jetzt loslegen -w-
12.04.2018 23:00:00

Global Genetic Testing Market Report 2017-2020 - Pharmacogenomics Drives Further Growth

DUBLIN, April 12, 2018 /PRNewswire/ --

The "The Global Genetic Testing Market 2017 to 2020 - By Direct to Consumer, Prenatal, Predictive & Pharmacogenomic including Test Price & Volume Forecasts with Executive & Consultant Guides" report has been added to ResearchAndMarkets.com's offering.

The report forecasts the market size out to 2020. The report includes detailed breakouts for 14 countries and 5 regions.

The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower pricing is driving the Genetic Testing industry to record growth. New drugs may only work for people with a certain genetic makeup, and this too is driving the Genetic Testing Industry. The traditional genetic testing market is growing in volume and growing in the breadth of tests creating new life for the industry.

Predictive Diagnostics? Pharmacogenomic Testing? Direct to Consumer? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five.

Market Trends

Factors Driving Growth

  • Genetic Discovery Creates New Diagnostic Markets
  • Aging Population a Boon for Diagnostics
  • Pharmacogenomics Drives Further Growth
  • Point of Care Testing Can Increase Demand
  • Fertility Practice
  • Direct to Consumer

Factors Limiting Growth

  • Increased Competition Lowers Price
  • Lower Costs
  • Testing Usage Analysis Curtailing Growth
  • Wellness Has a Downside

Companies Mentioned

  • 23andMe
  • AI
  • Abbott
  • AncestryDNA
  • Assurex Health
  • AstraZeneca
  • Athletigen
  • BGI Genomics Co. Ltd.
  • Capni
  • Centogene
  • Dante Labs
  • Edico Genome
  • Essentialis
  • Eurofins
  • GHO Capital
  • GeneInsight
  • Genesis Genetics
  • Helix
  • Human Longevity, Inc.
  • IBM Watson
  • Illumina
  • Invitae
  • Konica Minolta
  • MDxHealth
  • Optra Health
  • Oxford Nanopore Technologies
  • PacBridge Capital
  • Roche Molecular Diagnostics
  • Sedia Biosciences
  • Tele-genetic
  • Veritas Genetics
  • WGS
  • miRagen Therapeutics

Key Topics Covered

1. Introduction and Market Definition
1.1 Genetic Testing Definition In This Report
1.2 The Genomics Revolution
1.3 Market Definition
1.4 U.S. Medical Market and laboratory Testing - Perspective

2. Market Overview
2.1 Market Participants Play Different Roles
2.2 Genetic Tests - Types, Examples and Discussion
2.3 Industry Structure
2.4 Profiles of Key Companies
2.5 Market Shares of Key Genetics Players - Analysis

3. Market Trends
3.1 Factors Driving Growth
3.2 Factors Limiting Growth
3.3 Instrumentation and Automation
3.4 Diagnostic Technology Development

4. Genetic Testing Recent Developments
4.1 Recent Developments - Importance and How to Use This Section
4.2 Future goal in UK is for every cancer patient to have his or her whole genome sequenced
4.3 Human Longevity Launches Whole Genome Product, MassMutual Partnerships
4.4 Influence of Whole Genome Sequencing growing
4.5 Rady Children's and Edico Genome Extend WGS Collaboration
4.6 $1500 to sequence newborns in China
4.8 Eurofins Acquiring PerkinElmer's NTD Laboratory Services Business
4.9 GeneInsight Acquisition Boosts Sunquest's Clinical Genetics IT Platform
4.10 AstraZeneca taps gene pioneer Venter for huge drug-hunting sweep
4.11 The Cooper Companies' Women's Health Care Unit Acquires Genesis Genetics
4.12 Research Validates Preimplantation Genetic Diagnosis for Aneuploidy (PGD-A)
4.13 New Investments in Ancestry.com to Boost DNA Business
4.14 GHO Capital Announces Acquisition of DNA Diagnostics Center
4.15 Scientists discover new nanoparticle, dubbed exomeres, released by tumors
4.16 New DNA tests look for 190 diseases in newborn's genetic code
4.17 Cordlife, PlumCare Partner to Offer Genetic Testing Services in Asia
4.18 New genetic risk score could help guide screening decisions for prostate cancer
4.19 Tele-genetics pilot makes genetic counseling accessible
4.20 Digital Genetic Assistant OptraGURU Launches Today From Optra Health
4.21 PacBridge Capital Partners Invests C$12M in Contextual Genomics
4.22 MDxHealth 2017 Revenues Rise 35 Percent on Prostate Cancer Tests
4.23 From DNA To Disease: A Diagnosis Made In Under A Day
4.24 A New Tool Uses CRISPR to Uncover Genetic Mutations
4.25 Sophia Genetics Gains CE-IVD Mark for Leukemia Assay

5. Country Market Sizes - North America

6. Country Markets - Europe

7. Country Markets - Asia Pacific

8. Country Markets - Latin America, Africa & The Middle East

9. Global Market Summary

10. The Future of Genetic Testing

For more information about this report visit https://www.researchandmarkets.com/research/b6s7fm/global_genetic?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/global-genetic-testing-market-report-2017-2020---pharmacogenomics-drives-further-growth-300628899.html

SOURCE Research and Markets

Analysen zu SECURITAS ABmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

SECURITAS AB 11,60 -0,77% SECURITAS AB